Fisher Asset Management
OLMA icon

Fisher Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Fisher Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71M Sell
296,724
-3,032
-1% -$40.6K ﹤0.01% 497
2026
Q1 		$4.47M Buy
+299,756
New +$6.67M ﹤0.01% 474

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Fisher Asset Management's OLMA Position: Q2 2026 in Review

Fisher Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 1% in Q2 2026, selling an estimated $40.6K and leaving 296,724 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Fisher Asset Management first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.47M in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Fisher Asset Management held 296,724 shares of Olema Pharmaceuticals worth $3.71M as of Q2 2026.
  • Fisher Asset Management sold 3,032 Olema Pharmaceuticals shares in Q2 2026, an estimated $40.6K.
  • Olema Pharmaceuticals made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #497 holding.
  • Fisher Asset Management first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Fisher Asset Management's Olema Pharmaceuticals position peaked at $4.47M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.